Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

02 févr. 2015 02h45 HE | Source: Pluri Inc.

Pluristem Announces Significant New Finding From Its Phase I/II Muscle Injury Trial and Excellent Safety Profile for PLX-PAD Cells at Twelve Months

HAIFA, Israel, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapies, announced an important new finding from its...
13 janv. 2015 03h00 HE | Source: Pluri Inc.

Pluristem to Present at Two Cell Therapy Conferences in January 2015

HAIFA, Israel, Jan. 13, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:CM) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today it will be presenting...
12 janv. 2015 03h00 HE | Source: Pluri Inc.

Pluristem Issues Letter to Shareholders

HAIFA, Israel, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today issued a Letter to...
06 janv. 2015 03h30 HE | Source: Pluri Inc.

Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa

HAIFA, Israel, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has been...
22 déc. 2014 03h00 HE | Source: Pluri Inc.

New Published Data Show Pluristem's PLX Cells Protect Neurons

HAIFA, Israel, Dec. 22, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that a study of...
04 déc. 2014 03h00 HE | Source: Pluri Inc.

Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes

HAIFA, Israel, Dec. 4, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that it has entered...
01 déc. 2014 03h00 HE | Source: Pluri Inc.

Pluristem Granted Patent in Singapore for Its 3D Cell Expansion Technology

HAIFA, Israel, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today it has been granted...
25 nov. 2014 03h00 HE | Source: Pluri Inc.

Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific Conferences

HAIFA, Israel, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that Dr. Ohad...
12 nov. 2014 03h00 HE | Source: Pluri Inc.

Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications

HAIFA, Israel, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has been...
10 nov. 2014 03h00 HE | Source: Pluri Inc.

Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014

London Regenerative Medicine Network Meeting Alliance for Regenerative Medicine's 2nd Annual European Advanced Therapies Investor Day HAIFA, Israel, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Pluristem...

Page précédente